Literature DB >> 22152182

EQ-5D for the assessment of health-related quality of life and resource allocation in children: a systematic methodological review.

J Noyes1, R T Edwards.   

Abstract

OBJECTIVES: EQ-5D is widely used in studies with adults as a source of generic health-related quality of life information and utility weights to inform resource allocation decisions. This methodological systematic review describes the extent to which EQ-5D has been used in the evaluation of children's health care, assesses psychometric properties, and makes recommendations for future good practice.
METHODS: Systematic searches of databases and the Internet to identify studies published during 2000-2010 that either used EQ-5D with children younger than age 19 years as an outcome measure or reported psychometric data. Study characteristics, including measures and psychometric data, were extracted into tables for analysis.
RESULTS: We identified 29 studies that used four versions of the EQ-5D: adult EQ-5D, EQ-5D-Y, Dutch EQ-5D child, and extended with cognitive dimension, EQ-5D+C. Twelve of 29 studies did not specify the EQ-5D version used. Existing literature lacks detail on the specific use of EQ-5D and its potential effects on findings. Version use and psychometric properties were inadequately reported. There are large gaps in current knowledge of psychometric properties across all versions when used with children.
CONCLUSIONS: For reasons of comparability with resource use across adult and children's services, there are arguments for continued use of EQ-5D in studies with children. We recommend use of EQ-5D alongside children-specific quality of life measures and disease-specific measures. Researchers are encouraged to undertake methodological and philosophical analyses to better understand and improve evidence as to how adults who make decisions about resource allocation can best take account of children in decision making.
Copyright © 2011 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22152182     DOI: 10.1016/j.jval.2011.07.011

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  29 in total

1.  Predictors of self-reported health-related quality of life according to the EQ-5D-Y in chronically ill children and adolescents with asthma, diabetes, and juvenile arthritis: longitudinal results.

Authors:  Christiane Otto; Dana Barthel; Fionna Klasen; Sandra Nolte; Matthias Rose; Ann-Katrin Meyrose; Marcus Klein; Ute Thyen; Ulrike Ravens-Sieberer
Journal:  Qual Life Res       Date:  2017-11-30       Impact factor: 4.147

2.  Population-based normative data for the Scoliosis Research Society 22r questionnaire in adolescents and adults, including a comparison with EQ-5D.

Authors:  Elias Diarbakerli; Anna Grauers; Paul Gerdhem
Journal:  Eur Spine J       Date:  2016-11-10       Impact factor: 3.134

Review 3.  Estimates of utility weights in hemophilia: implications for cost-utility analysis of clotting factor prophylaxis.

Authors:  Scott D Grosse; Shraddha S Chaugule; Joel W Hay
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2015-01-14       Impact factor: 2.217

Review 4.  EQ-5D in Central and Eastern Europe: 2000-2015.

Authors:  Fanni Rencz; László Gulácsi; Michael Drummond; Dominik Golicki; Valentina Prevolnik Rupel; Judit Simon; Elly A Stolk; Valentin Brodszky; Petra Baji; Jakub Závada; Guenka Petrova; Alexandru Rotar; Márta Péntek
Journal:  Qual Life Res       Date:  2016-07-29       Impact factor: 4.147

5.  A review of preference-based measures for the assessment of quality of life in children and adolescents with cerebral palsy.

Authors:  Christine Mpundu-Kaambwa; Gang Chen; Elisabeth Huynh; Remo Russo; Julie Ratcliffe
Journal:  Qual Life Res       Date:  2018-03-22       Impact factor: 4.147

6.  Once Bitten Twice Shy: Thinking Carefully Before Adopting the EQ-5D-5L.

Authors:  Jeff Round
Journal:  Pharmacoeconomics       Date:  2018-06       Impact factor: 4.981

Review 7.  A Review of the Development and Application of Generic Multi-Attribute Utility Instruments for Paediatric Populations.

Authors:  Gang Chen; Julie Ratcliffe
Journal:  Pharmacoeconomics       Date:  2015-10       Impact factor: 4.981

8.  Measurement of utility in asthma: evidence indicating that generic instruments may miss clinically important changes.

Authors:  Patrick W Sullivan; Vahram H Ghushchyan; Jonathan D Campbell; Gary Globe; Bruce Bender; David J Magid
Journal:  Qual Life Res       Date:  2016-07-07       Impact factor: 4.147

9.  Validity and responsiveness of the EQ-5D and the KIDSCREEN-10 in children with ADHD.

Authors:  Clazien Bouwmans; Annemarie van der Kolk; Mark Oppe; Saskia Schawo; Elly Stolk; Michel van Agthoven; Jan Buitelaar; LeonaHakkaart van Roijen
Journal:  Eur J Health Econ       Date:  2014-12

10.  Health-related quality of life of children and adolescents with functional disabilities in a northern Swedish county.

Authors:  Erik Domellöf; Ludmilla Hedlund; Pia Ödman
Journal:  Qual Life Res       Date:  2013-12-31       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.